Literature DB >> 6325904

Hypokalemic periodic paralysis: in vitro investigation of muscle fiber membrane parameters.

R Rüdel, F Lehmann-Horn, K Ricker, G Küther.   

Abstract

To study the mechanism of attacks in familial hypokalemic paralysis, we recorded resting membrane potentials, action potentials, current-voltage relationships, and isometric forces in intercostal muscle fibers from three patients. In normal extracellular medium, the resting potential was reduced, but membrane conductance was not different from control. Excitability was reduced and the action potentials had no overshoot. On exposure to a 1-mM potassium solution, with or without insulin, the cells depolarized to about -50 mV, and became inexcitable. Over the tested membrane potential range from -120 to -40 mV, the slope conductance in the 1-mM potassium solution was not different from that of control fibers in a 1-mM potassium solution. In particular, the potassium component conductance was not reduced. Depolarized fibers could not be completely repolarized by returning to a 3.5-mM potassium solution. An experimentally induced transient shift of the chloride equilibrium potential to a highly negative value caused stable repolarization. Paralysis could also be induced by replacement of extracellular chloride with an impermanent anion, a treatment which causes myotonia in healthy fibers. It was concluded that the basic defects are a reduced excitability and an increased sodium conductance, and that these defects are aggravated on reduction of the extracellular potassium concentration.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6325904     DOI: 10.1002/mus.880070205

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  46 in total

1.  The human skeletal muscle Na channel mutation R669H associated with hypokalemic periodic paralysis enhances slow inactivation.

Authors:  A F Struyk; K A Scoggan; D E Bulman; S C Cannon
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

Review 2.  Periodic paralysis: understanding channelopathies.

Authors:  Frank Lehmann-Horn; Karin Jurkat-Rott; Reinhardt Rüdel
Journal:  Curr Neurol Neurosci Rep       Date:  2002-01       Impact factor: 5.081

Review 3.  Skeletal muscle sodium current is reduced in hypokalemic periodic paralysis.

Authors:  R L Ruff
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

4.  Diabetic state-induced modification of resting membrane potential and conductance in diaphragm muscle of alloxan and diabetic KK-CAy mice.

Authors:  M Kimura; I Kimura; T Nakamura; H Nojima
Journal:  Diabetologia       Date:  1988-02       Impact factor: 10.122

Review 5.  Muscle channelopathies and critical points in functional and genetic studies.

Authors:  Karin Jurkat-Rott; Frank Lehmann-Horn
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

Review 6.  Inherited disorders of voltage-gated sodium channels.

Authors:  Alfred L George
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

Review 7.  Ion channels and ion transporters of the transverse tubular system of skeletal muscle.

Authors:  Karin Jurkat-Rott; Michael Fauler; Frank Lehmann-Horn
Journal:  J Muscle Res Cell Motil       Date:  2006-08-24       Impact factor: 2.698

Review 8.  Diagnostics and therapy of muscle channelopathies--Guidelines of the Ulm Muscle Centre.

Authors:  F Lehmann-Horn; K Jurkat-Rott; R Rüdel
Journal:  Acta Myol       Date:  2008-12

9.  Bumetanide prevents transient decreases in muscle force in murine hypokalemic periodic paralysis.

Authors:  Fenfen Wu; Wentao Mi; Stephen C Cannon
Journal:  Neurology       Date:  2013-02-20       Impact factor: 9.910

10.  Gating pore currents in DIIS4 mutations of NaV1.4 associated with periodic paralysis: saturation of ion flux and implications for disease pathogenesis.

Authors:  Arie F Struyk; Vladislav S Markin; David Francis; Stephen C Cannon
Journal:  J Gen Physiol       Date:  2008-10       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.